虚高药价的成因及治理策略探讨  

Discussion on the Causes and Treatment Strategies of Artificially High Drug Prices

作　　者：张维斌[1] 

机构地区：[1]重庆市肿瘤研究所/重庆市肿瘤医院,重庆400030

出　　处：《中国药房》2016年第22期3028-3031,共4页China Pharmacy

基　　金：重庆市决策咨询与管理创新计划项目(No.cstc2014-jccxB10002)

摘　　要：目的:探讨虚高药价的成因及相关治理策略。方法:从药品价格形成、药品流通及交易、医疗机构使用等方面系统地分析虚高药价的成因,提出治理虚高药价的总体思路和实施策略。结果与结论:定价机制不健全、药品流通环节众多、采购交易制度不完善、医疗机构的"以药补医"机制等多种因素导致了虚高药价的形成。建议治理虚高药价应从健全药品价格市场形成机制、推进药品流通领域改革、完善药品集中采购交易机制入手,同时加快医保支付制度改革、深化公立医疗机构运行机制改革和健全药品综合监管法律法规,以逐步完善药品价格管理制度,实现药品合理定价。OBJECTIVE：To discuss the causes and related treatment strategies of artificially high drug prices. METHODS：The causes of artificially high drug prices were analyzed from drug price formation,distribution and trading,drug use in medical institutions and other aspects,in order to sort out the overall plan and treatment strategies of artificially high drug prices. RESULTS CONCLUSIONS：Artificially high drug prices are resulted from not sound pricing mechanism,numerous circulation links,imperfect procurement system,＂drug maintaining medicine＂mechanism of medical institutions and other factors. It is suggested to solve artificially high drug prices from perfecting drug market price formation mechanism,promoting circulation reform,improving centralized purchasing trading mechanism;at the same time,accelerating the reform of medicare payment system,deepening the reform of public medical institutions operating mechanism and perfecting supervision laws and regulations so as to gradually improve the drug price administration system and realize reasonable drug pricing.

关 键 词：药品价格 虚高药价 成因 治理策略 

分 类 号：R95[医药卫生—药学]